Trials / Completed
CompletedNCT05120128
Changes in Inflammatory Biomarkers When Symptomatic Contact Lens Wearers Are Refit in Acuvue Oasys 1-Day Lenses
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 34 (actual)
- Sponsor
- Johnson & Johnson Vision Care, Inc. · Industry
- Sex
- All
- Age
- 18 Years – 60 Years
- Healthy volunteers
- Accepted
Summary
This is a 5-Visit, single-arm, single-site, subject masked, dispensing trial to evaluate contact lens discomfort and inflammatory biomarker expression.
Detailed description
The study will assess device feasibility for up to 10 habitual wearers of 4 different types of marketed contact lens.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Acuvue® Oasys 1-Day | TEST Lens |
Timeline
- Start date
- 2021-11-24
- Primary completion
- 2022-12-13
- Completion
- 2022-12-13
- First posted
- 2021-11-15
- Last updated
- 2023-11-08
Locations
1 site across 1 country: United Kingdom
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT05120128. Inclusion in this directory is not an endorsement.